Petmed Express (PETS) Liabilities and Shareholders Equity (2011 - 2025)

Petmed Express has reported Liabilities and Shareholders Equity for 15 years, with the latest figure at $88.0 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 39.25% year-over-year to $88.0 million; the trailing twelve-month figure through Dec 2025 stood at $446.8 million (down 27.16% YoY), and the FY2025 full-year result was $148.7 million, down 12.47% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $88.0 million, down from $100.3 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $187.5 million in Q1 2021, with the low at $88.0 million in Q4 2025.
• Historically, Liabilities and Shareholders Equity has averaged $156.0 million across 5 years, with a median of $166.1 million in 2022.
• Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity grew 20.71% — and 2025, when it tumbled 39.25%.
• Petmed Express' Liabilities and Shareholders Equity stood at $168.4 million in 2021, then gained by 0.7% to $169.6 million in 2022, then climbed by 2.2% to $173.4 million in 2023, then slipped by 16.47% to $144.8 million in 2024, then plunged by 39.25% to $88.0 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $88.0 million (Q4 2025), $100.3 million (Q3 2025), and $109.8 million (Q2 2025), per Business Quant data.